Brief: Scinai Immunotherapeutics Announces $10 Million Standby Equity Purchase Agreement
March 5 (Reuters) - Scinai Immunotherapeutics Ltd 2F5y.F: SCINAI IMMUNOTHERAPEUTICS ANNOUNCES $10 MILLION STANDBY EQUITY PURCHASE AGREEMENT SCINAI IMMUNOTHERAPEUTICS LTD - SALES TO YORKVILLE SUBJECT TO 9.99% BENEFICIAL OWNERSHIP CAP Source text: ID:nPn36TNfza Further company coverage: [2F5y.F] (Reuters.Briefs@thomsonreuters.com)